Clinical Chemistry Podcast RSS
Summary: This free monthly podcast is part of Clinical Chemistry. Clinical Chemistry is the leading forum for peer-reviewed, original research on innovative practices in today's clinical laboratory. In addition to being the most cited journal in the field (26,500 citations in 2014), Clinical Chemistry has the highest Impact Factor (7.9 in 2014) among journals of clinical chemistry, clinical (or anatomic) pathology, analytical chemistry, and the subspecialties, such as transfusion medicine, clinical microbiology.
- Visit Website
- RSS
- Artist: American Association for Clinical Chemistry
- Copyright: The contents of material available on this Web site are copyrighted by AACC unless otherwise indicated. Copyright is not claimed as to any part of an original work prepared by a U.S. or state government officer or employee as part of that person's offici
Podcasts:
Unraveling the molecular mechanisms that regulate the biology of metastasis-competent circulating tumor cells (CTCs) is urgently needed to understand metastasis formation and tumor relapse.
This is the April 2017 issue of Clinical Chemistry, Volume 63, Issue 2.
This is the February 2017 issue of Clinical Chemistry, Volume 63, Issue 2.
Cannabis and its products are the most widely used illicit drugs world-wide, with the majority of countries currently harboring consumers and producers. Medicalization and legalization of the drug...
Monitoring of glycemic control with hemoglobin A1c (A1c) in hemodialysis patients may be compromised by anemia and erythropoietin therapy.
Disorders of bone metabolism, most notably osteoporosis, are highly prevalent and predispose to fractures, causing high patient morbidity and mortality.
Every year, commercial testing labs earn millions of dollars from selling the anonymized results of blood, urine, tissue, and other tests with almost no public scrutiny or debate.2 Few outside the industry know anything about this trade, and lab workers are often in the dark as well.
In addition to focusing on the publication of cutting-edge scientific reports, Clinical Chemistry has shown a genuine commitment to education by devoting a substantial portion of its pages to educational articles since 2008.
Interpretation of serial high-sensitivity cardiac troponin (hs-cTn) measurements for the diagnosis of acute myocardial infarction (AMI) assumes random fluctuation of hs-cTn around an individual's homeostatic set point.
Researchers have developed approaches for the noninvasive prenatal testing of single gene diseases.
Quantifying the variability of biomarkers is important, as high within-person variability can lead to misclassification of individuals. Short-term variability of important markers of vitamin D metabolism is relatively unknown.
This is the January2017 issue of Clinical Chemistry, Volume 63, Issue 1.
Patients with chest pain comprise a large proportion of emergency presentations and place a major burden on healthcare resources.
Pulmonary embolism (PE) is associated with high all-cause and PE-related mortality and requires individualized management.
The development and implementation of sensitive and high-sensitivity cardiac troponin assays has not only expedited the early ruling in and ruling out of acute myocardial infarction, but has also contributed to the identification of patients at risk for myocardial injury with necrosis, as confirmed by the presence of cardiac troponin concentrations above the 99th percentile.
